Kater AP - Search Results

1

Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands.

Dinmohamed AG, Posthuma EFM, Visser O, Kater AP, Raymakers RAP, Doorduijn JK. Dinmohamed AG, et al. Among authors: kater ap. Blood. 2018 Mar 22;131(12):1380-1383. doi: 10.1182/blood-2017-12-820381. Epub 2018 Jan 30. Blood. 2018. PMID: 29382643 Free article. No abstract available.

2

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity.

Smit LA, Hallaert DY, Spijker R, de Goeij B, Jaspers A, Kater AP, van Oers MH, van Noesel CJ, Eldering E. Smit LA, et al. Among authors: kater ap. Blood. 2007 Feb 15;109(4):1660-8. doi: 10.1182/blood-2006-05-021683. Epub 2006 Oct 12. Blood. 2007. PMID: 17038534 Free article.

3

Cellular immune therapy for chronic lymphocytic leukemia.

Kater AP, van Oers MH, Kipps TJ. Kater AP, et al. Blood. 2007 Oct 15;110(8):2811-8. doi: 10.1182/blood-2007-01-068932. Epub 2007 Jul 16. Blood. 2007. PMID: 17638850 Free article. Review.

4

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.

Tonino SH, Spijker R, Luijks DM, van Oers MH, Kater AP. Tonino SH, et al. Among authors: kater ap. Blood. 2008 Aug 1;112(3):840-3. doi: 10.1182/blood-2008-03-144576. Epub 2008 Jun 2. Blood. 2008. PMID: 18519815 Free article.

5

c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches.

Hallaert DY, Jaspers A, van Noesel CJ, van Oers MH, Kater AP, Eldering E. Hallaert DY, et al. Among authors: kater ap. Blood. 2008 Dec 15;112(13):5141-9. doi: 10.1182/blood-2008-03-146704. Epub 2008 Sep 16. Blood. 2008. PMID: 18796631 Free article.

6

Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008.

van den Broek EC, Kater AP, van de Schans SA, Karim-Kos HE, Janssen-Heijnen ML, Peters WG, Nooijen PT, Coebergh JW, Posthuma EF. van den Broek EC, et al. Among authors: kater ap. Eur J Cancer. 2012 Apr;48(6):889-95. doi: 10.1016/j.ejca.2011.06.053. Epub 2011 Jul 25. Eur J Cancer. 2012. PMID: 21795040 Free article.

7

Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study.

Kater AP, Spiering M, Liu RD, Doreen Te Raa G, Slinger E, Tonino SH, Beckers MM, Daenen S, Doorduijn JK, Lankheet NA, Luijks DM, Eldering E, van Oers MH. Kater AP, et al. Leuk Res. 2014 Jan;38(1):34-41. doi: 10.1016/j.leukres.2013.10.004. Epub 2013 Oct 28. Leuk Res. 2014. PMID: 24238639 Clinical Trial.

8

CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia.

te Raa GD, Pascutti MF, García-Vallejo JJ, Reinen E, Remmerswaal EB, ten Berge IJ, van Lier RA, Eldering E, van Oers MH, Tonino SH, Kater AP. te Raa GD, et al. Among authors: kater ap. Blood. 2014 Jan 30;123(5):717-24. doi: 10.1182/blood-2013-08-518183. Epub 2013 Nov 18. Blood. 2014. PMID: 24246502 Free article.

9

miR in CLL: more than mere markers of prognosis?

Kater AP, Eldering E. Kater AP, et al. Blood. 2014 Jul 3;124(1):2-4. doi: 10.1182/blood-2014-05-574152. Blood. 2014. PMID: 24993874 Free article.

10

How does lenalidomide target the chronic lymphocytic leukemia microenvironment?

Kater AP, Tonino SH, Egle A, Ramsay AG. Kater AP, et al. Blood. 2014 Oct 2;124(14):2184-9. doi: 10.1182/blood-2014-05-578286. Epub 2014 Aug 26. Blood. 2014. PMID: 25161268 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters